Online citations, reference lists, and bibliographies.
← Back to Search

Resveratrol-loaded Solid Lipid Nanoparticles Versus Nanostructured Lipid Carriers: Evaluation Of Antioxidant Potential For Dermal Applications

E. Gokce, E. Korkmaz, E. Dellera, G. Sandri, M. C. Bonferoni, O. Ozer
Published 2012 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Background Excessive generation of radical oxygen species (ROS) is a contributor to skin pathologies. Resveratrol (RSV) is a potent antioxidant. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) can ensure close contact and increase the amount of drug absorbed into the skin. In this study, RSV was loaded into SLN and NLC for dermal applications. Methods Nanoparticles were prepared by high shear homogenization using Compritol 888ATO, Myglyol, Poloxamer188, and Tween80. Particle size (PS), polydispersity index (PI), zeta potential (ZP), drug entrapment efficiency (EE), and production yield were determined. Differential scanning calorimetry (DSC) analysis and morphological transmission electron microscopy (TEM) examination were conducted. RSV concentration was optimized with cytotoxicity studies, and net intracellular accumulation of ROS was monitored with cytofluorimetry. The amount of RSV was determined from different layers of rat abdominal skin. Results PS of uniform RSV-SLN and RSV-NLC were determined as 287.2 nm ± 5.1 and 110.5 nm ± 1.3, respectively. ZP was −15.3 mV ± 0.4 and −13.8 mV ± 0.1 in the same order. The drug EE was 18% higher in NLC systems. TEM studies showed that the drug in the shell model was relevant for SLN, and that the melting point of the lipid in NLC was slightly lower. Concentrations below 50 μM were determined as suitable RSV concentrations for both SLN and NLC in cell culture studies. RSV-NLC showed less fluorescence, indicating less ROS production in cytofluorometric studies. Ex vivo skin studies revealed that NLC are more efficient in carrying RSV to the epidermis. Conclusion This study suggests that both of the lipid nanoparticles had antioxidant properties at a concentration of 50 μM. When the two systems were compared, NLC penetrated deeper into the skin. RSV-loaded NLC with smaller PS and higher drug loading appears to be superior to SLN for dermal applications.
This paper references
10.1023/B:PHAM.0000019291.36636.c1
Structural Characterization of Q10-Loaded Solid Lipid Nanoparticles by NMR Spectroscopy
Sylvia A. Wissing (2004)
10.1158/1078-0432.CCR-07-0347
Resveratrol Inhibits Tumor Growth of Human Neuroblastoma and Mediates Apoptosis by Directly Targeting Mitochondria
P. R. van Ginkel (2007)
10.1016/S0006-291X(03)00641-7
Method to overcome photoreaction, a serious drawback to the use of dichlorofluorescin in evaluation of reactive oxygen species.
M. Afzal (2003)
10.1016/J.IJPHARM.2007.03.022
Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.
Veerawat Teeranachaideekul (2007)
10.1080/10715760600570547
AROS-29 is involved in adaptive response to oxidative stress
N. Montesano Gesualdi (2006)
10.1208/pt070364
Evaluation of alternative strategies to optimize ketorolac transdermal delivery
C. Puglia (2008)
10.1016/j.arr.2007.08.006
Role of novel delivery systems in developing topical antioxidants as therapeutics to combat photoageing
I. P. Kaur (2007)
10.1021/MP060040V
Increased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylation.
M. E. Hayes (2006)
10.1016/S1011-1344(97)00021-3
Photocarcinogenesis: an overview.
P. Forbes (1981)
10.1016/J.IJPHARM.2006.02.045
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
R. Mueller (2006)
Reactive Oxygen Species in Biological Systems: An Interdisciplinary Approach
L. G. Daniel (2013)
10.1080/026520499288690
Solid lipid nanoparticles (SLN/Lipopearls)--a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products.
A. Dingler (1999)
10.1016/j.colsurfb.2009.03.032
Stearyl ferulate-based solid lipid nanoparticles for the encapsulation and stabilization of beta-carotene and alpha-tocopherol.
S. Trombino (2009)
10.1002/EJLT.200401075
Fractional crystallisation – the fat modification process for the 21st century
R. E. Timms (2005)
10.1007/0-306-46806-9_2
Chemistry of Reactive Oxygen Species
R. E. Huie (2002)
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
10.1016/J.BIOPHA.2007.05.010
Interplay among oxidants, antioxidants, and cytokines in skin disorders: present status and future considerations.
Meital Portugal (2007)
Nanoparticulate drug delivery systems. informa Healthcare U s A, inc
Eb Souto (2007)
10.1016/j.jbiotec.2010.01.001
3D-wound healing model: influence of morphine and solid lipid nanoparticles.
S. Küchler (2010)
10.1016/S0378-5173(00)00378-1
Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids.
V. Jenning (2000)
10.1208/s12249-009-9193-6
Physicochemical Characteristics, Cytotoxicity, and Antioxidant Activity of Three Lipid Nanoparticulate Formulations of Alpha-lipoic Acid
U. Ruktanonchai (2009)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1016/S0169-409X(97)00128-2
Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo.
Cullis (1998)
10.1111/1523-1747.EP12613740
Skin inflammation: reactive oxygen species and the role of iron.
C. W. Trenam (1992)
10.1016/j.ijpharm.2008.07.028
Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.
E. Gokce (2008)
10.1016/j.ijpharm.2009.10.011
The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol.
K. Teskač (2010)
10.1201/9781420008449
Nanoparticulate Drug Delivery Systems
Deepak Thassu (2007)
Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives
Melike Üner (2007)
Nanoparticulate drug delivery systems. informa Healthcare
EB Souto (2007)
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery
E. B. Soutoa (2004)
10.1016/S1383-5718(01)00233-9
Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cells.
J. Jang (2001)
10.1016/j.jconrel.2009.11.013
Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin.
T. Şenyiğit (2010)
10.1016/j.ijpharm.2008.10.003
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
J. Pardeike (2009)
UV-induced reactive oxygen species in photocarcinogenesis and photoaging.
K. Scharffetter-Kochanek (1997)
10.1016/j.bbamem.2009.06.005
Interaction of the chemopreventive agent resveratrol and its metabolite, piceatannol, with model membranes.
O. Wesołowska (2009)
10.1080/02652040010000361
Encapsulation of retinoids in solid lipid nanoparticles (SLN).
V. Jenning (2001)
10.1016/S0041-008X(02)00014-5
Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice.
F. Afaq (2003)
Fractionation of fats
D. Illingworth (2002)
10.1007/978-1-4613-2265-8_2
Chemistry of Reactive Oxygen Species
C. Foote (1985)



This paper is referenced by
Topical and Transdermal Benefits of Nanostructured Lipid Carriers
M. Ashwini (2019)
10.1016/j.colsurfa.2020.124739
Plant growth induction by volatile organic compound released from solid lipid nanoparticles and nanostructured lipid carriers
P. Fincheira (2020)
Preparação, caracterização de nanoparticulas contendo resveratrol e avaliação do efeito fotoprotetor in vitro frente à peroxidação lipídica causada pela radiação solar
Mayan Cavalcanti Spach (2017)
10.1016/j.colsurfb.2013.05.041
Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity.
A. Mendes (2013)
10.1002/EJLT.201800125
Preparation and Physicochemical Properties of a Cysteine Derivative‐Loaded Deformable Liposomes in Hydrogel for Enhancing Whitening Effects
J. H. Ha (2018)
10.3390/nu8030131
Nanoscale Delivery of Resveratrol towards Enhancement of Supplements and Nutraceuticals
A. Neves (2016)
10.1016/j.ejpb.2014.12.023
Current nanotechnology approaches for the treatment and management of diabetic retinopathy.
J. Fangueiro (2015)
10.2147/IJN.S40519
Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations
I. Özcan (2013)
10.1049/IET-NBT.2018.5312
Development of nanotechnology for advancement and application in wound healing: a review.
Debalina Bhattacharya (2019)
10.31695/ijasre.2018.32935
Development Nanostructured Lipid Carriers (Nlc) Loaded Resveratrol with Different Combination of Soybean Oil and Oleic Acid
Rohmawati Hidayah (2018)
10.1007/978-3-030-35147-2
Nanotechnology in Skin, Soft Tissue, and Bone Infections
M. Rai (2020)
10.1016/j.ijpharm.2018.06.065
Self‐microemulsifying tablets prepared by direct compression for improved resveratrol delivery
Katarina Bolko Seljak (2018)
Nanocarriers as alternative strategies for treatment of mycobacterial infections
A. C. Vieira (2017)
10.3390/antiox8080272
Evaluation of the Influence of Process Parameters on the Properties of Resveratrol-Loaded NLC Using 22 Full Factorial Design
A. Shimojo (2019)
10.3109/03639045.2016.1151028
Topical delivery of paclitaxel for treatment of skin cancer
Rituraj Bharadwaj (2016)
10.1016/j.ejps.2018.06.034
Melatonin vitamin C‐based nanovesicles for treatment of androgenic alopecia: Design, characterization and clinical appraisal
Shymaa Hatem (2018)
10.1016/j.ijpharm.2020.119476
Neuroprotection by curcumin: a review on brain delivery strategies.
Anis Askarizadeh (2020)
10.3390/antiox8080244
Strategies to Improve Resveratrol Systemic and Topical Bioavailability: An Update
Sebastiano Intagliata (2019)
10.1016/J.MICROMESO.2016.04.001
Experimental and theoretical study of quercetin complexes formed on pure silica and Zn-modified mesoporous MCM-41 and SBA-16 materials
M. Popova (2016)
10.1155/2014/903646
Oridonin Loaded Solid Lipid Nanoparticles Enhanced Antitumor Activity in MCF-7 Cells
L. Wang (2014)
10.3390/pharmaceutics9040058
Resveratrol-Loaded Lipid Nanocarriers: Correlation between In Vitro Occlusion Factor and In Vivo Skin Hydrating Effect
L. Montenegro (2017)
10.1007/978-3-319-13596-0
Food Nanoscience and Nanotechnology
H. Hernández-Sánchez (2015)
10.1007/s00403-019-01930-z
Implications of grape extract and its nanoformulated bioactive agent resveratrol against skin disorders
S. Soleymani (2019)
10.1016/j.toxlet.2014.05.018
Targeting Nrf2-Keap1 signaling for chemoprevention of skin carcinogenesis with bioactive phytochemicals.
Kyung-soo Chun (2014)
10.15171/apb.2016.072
Nanostructured Lipid Carrier for Topical Application of N-Acetyl Glucosamine.
Lavin Aliasgharlou (2016)
Development of Solid Lipid-polymer Hybrid Nanoparticles as Potential Oral Delivery Systems for Lipophilic Bioactive Compounds
Taoran Wang (2019)
10.3109/03639045.2014.972412
In vitro lipolysis tests on lipid nanoparticles: comparison between lipase/co-lipase and pancreatic extract
V. Jannin (2015)
Solid Lipid Nanoparticles: Overview on Excipients
P. JatinB. (2013)
Study of the cytotoxicity of raw materials of cosmetic and topical pharmaceutical formulations
V. Rocha (2015)
In vitro studies on the effect of red wine polyphenols and cyclic guanosine monophosphate export in the regulation of vascular and erectile tone
C. Boydens (2017)
10.5772/INTECHOPEN.79739
Novel Drug Delivery Systems of Resveratrol to Bioavailability and Therapeutic Effects
P. Devi (2019)
10.1039/c8fo01172a
Enhanced pH and thermal stability, solubility and antioxidant activity of resveratrol by nanocomplexation with α-lactalbumin.
Yuexiang Liu (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar